4주물 국채 입찰 결과
CUSIP: 912797US4 만기·종류: 4주물 국채 CMB: No 최고 금리: 3.605% 투자 수익률: 3.665% 가격: $99.719611 최고금리 배정…
관련 뉴스
YOUFIRESearch
검색
섹터, 종목, 뉴스 키워드를 한 번에 찾습니다.
Butler National Corporation (BUKS) Q4 2026 실적 Call Transcript
관련 뉴스I Have Been Waiting Patiently For This Q3 Selloff
관련 뉴스Seres Therapeutics, Inc. (MCRB) Discusses Promising SER-155 Clinical Trial Results for Immune Checkpoint Inhibitor Related Andropilatis - Slideshow
관련 뉴스Chemomab Therapeutics Ltd. (CMMB) M&A Call Prepared Remarks Transcript
관련 뉴스Palm Valley Capital Fund Q2 2026 Portfolio Activity
관련 뉴스Palm Valley Capital Fund Q2 2026 Letter
관련 뉴스MasTec, Inc. (MTZ) M&A Call Transcript
관련 뉴스Enerpac Tool Group Corp. (EPAC) Q3 2026 실적 Call Transcript
관련 뉴스Enerpac Tool Group Corp. 2026 Q3 - Results - 실적 Call Presentation
Enerpac Tool Group Corp. 2026 Q3 - Results 핵심만 확인.
관련 뉴스
YOUFIRE · you-are-fire.comEarly Q3 Trend Reversal
관련 뉴스Match Group, IBD's 주식 Of The Day, Pins Hopes On Hinge, Tinder And AI-Led Growth
관련 뉴스JPMorgan Chase: Here's One Trade To Consider 속 실적 Approach
관련 뉴스Bank of America Affirms Why NVIDIA Corp. (NVDA) is a Top AI 주식 on Wall Street Radar
관련 뉴스American Express: Upgrading To Buy Ahead Of 실적
관련 뉴스Is Genmab A/S (GMAB) 주식 Undervalued After Positive Epkinly DLBCL Trial Results?
관련 뉴스NextGen FinCrime 2026: How non-financial sectors can replicate banks’ success in fraud prevention
At the inaugural NextGen FinCrime event in 2026, Emma Lindley MBE kicked off sessions with…
관련 뉴스Seres Therapeutics, Inc. (MCRB) Discusses Promising SER-155 Clinical Trial Results for Immune Checkpoint Inhibitor Related Andropilatis Transcript
관련 뉴스North Sky Capital Q2 2026 Commentary
관련 뉴스Micron 실적: I Was Worried For Nothing (Rating Upgrade)
관련 뉴스Is TransMedics Group, Inc. (TMDX) 주식 Still a MedTech Growth Opportunity After Analyst Target Cut?
관련 뉴스Unite Group PLC (UTGPF) Q2 2026 Sales/Trading Call Transcript
관련 뉴스Saratoga Investment Corp 2027 Q1 - Results - 실적 Call Presentation
Saratoga Investment Corp 2027 Q1 - Results 핵심만 확인.
관련 뉴스These Nuclear Energy 주식 Slumped in the First Half of 2026. Buy This 1 On the Dip. - The Motley Fool
The Motley Fool These Nuclear Energy 주식 Slumped in the First Half of 2026.
관련 뉴스MasTec, Inc. (MTZ) The Superior Group Inc. - M&A Call - Slideshow
MasTec, Inc. (MTZ) The Superior Group Inc. - M&A Call 핵심만 확인.
관련 뉴스4 Investing Themes For The Second Half Of 2026
관련 뉴스Prediction: Eli Lilly 주식 Will Hit This Price by the End of 2026 - The Motley Fool
관련 뉴스Vox Royalty: Revenue Understates The Business, 실적 Overstate It
관련 뉴스VNET Group: A Data Center Utility Priced For AI Perfection
관련 뉴스AI disruption is the hot topic of 실적 calls
관련 뉴스비트코인 and ethereum prices today, Wednesday, July 8, 2026: 가상자산 prices down following U.S.-Iran strikes
관련 뉴스SEC Small Business Advisory Committee to Explore Modernizing 시장 Access
The Securities and Exchange Commission’s Small Business Capital Formation Advisory Committe…
관련 뉴스주식 Picks From Seeking Alpha's June 2026 New Analysts
관련 뉴스Here’s How Much Delta Air Lines 주식 Is Expected to Move After 실적 - Investopedia
관련 뉴스Helen of Troy Q1: Results Support Outperformance
관련 뉴스Silver prices today, Wednesday, July 8, 2026: Silver slips below $60 once again following airstrikes
관련 뉴스What Makes Vontier Corp. (VNT) an Investment Bet?
관련 뉴스Goldman Sachs vs. Interactive Brokers: Which Financial 주식 Is a Better Buy in 2026? - The Motley Fool
The Motley Fool Goldman Sachs vs.
관련 뉴스